+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 20Years +
All Genders
ID07846423

Evaluating Abbott ID NOW Rapid Molecular Testing Compared to Standard Laboratory Diagnosis for Influenza in Long-Term Care Facility Residents in Taiwan A Cluster-Randomized Controlled Trial

Led by China Medical University Hospital · Updated on 2026-09-29

1080

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate whether rapid point-of-care molecular testing for influenza in long-term care facility residents can improve clinical outcomes and reduce healthcare costs compared to the current standard diagnostic approach. The study focuses on elderly residents who are at high risk for severe illness and complications due to multiple chronic conditions and age-related immune decline. It addresses the challenge of delayed influenza diagnosis that may hinder timely treatment and increase resource use in these settings. The study compares two diagnostic strategies an Abbott ID NOW point-of-care molecular testing system that provides results within about 15 minutes using nasal or nasopharyngeal swabs collected on site, and the standard laboratory-based RT-PCR testing with a 24 to 48-hour turnaround time. Eligible residents with suspected influenza-like illness in selected rooms of participating long-term care facilities will be randomized to either the rapid testing group or the standard diagnostic pathway. The study is open-label and conducted in multiple facilities across Taiwan. Participants will be enrolled when they develop symptoms meeting specified criteria and followed for 30 days after the illness episode. Data on clinical outcomes, healthcare use, and timing from specimen collection to test result availability will be collected. The primary outcome measures the time from specimen collection to influenza test result availability within 48 hours. The study aims to assess whether rapid testing can support faster clinical decisions, improve patient management, and reduce unnecessary healthcare resources in long-term care settings.

CONDITIONS

Brief Title

Abbott ID NOW Point-of-Care Testing

Research Team

C

Chia-Hui Tan, Ph.D

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here